Molecular signature of cancer stem cells isolated from prostate carcinoma and expression of stem markers in different Gleason grades and metastasis

Biological Research

Volumn 45, Issue 3, 2012, Pages 294-305

  Castellón, Enrique A ^a   Valenzuela, Rodrigo ^a   Lillo, Jorge ^a   Castillo, Viviana ^a   Contreras, Héctor R ^a   Gallegos, Iván ^b   Mercado, Alejandro ^a,b   Huidobro, Christian ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Cancer stem cell; Prostate cancer; Spheres cultures

Indexed keywords

LEUKOCYTE ANTIGEN; TUMOR MARKER;

BIOPSY; BONE TUMOR; CANCER GRADING; CANCER STEM CELL; CELL SEPARATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SECONDARY; TUMOR RECURRENCE; TUMOR STEM CELL ASSAY; ARTICLE; DRUG SCREENING;

ANTIGENS, CD; BIOMARKERS, TUMOR; BIOPSY; BONE NEOPLASMS; CELL SEPARATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR STEM CELL ASSAY; TUMOR MARKERS, BIOLOGICAL;

EID: 84871487734     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/s0716-97602012000300011     Document Type: Article

References (62)

1. BARRANDON Y and GREEN H (1985) Cell size as a determinant of the clone-forming ability of human keratinocytes. Proc Natl Acad Sci USA 82: 5390-4.
2. BONNET D and DICK JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-37.
3. BORST P, JONKERS J and ROTTENBERG S (2007) What Makes Tumors Multidrug Resistant? Cell Cycle 6:2782-87.
4. CABANILLAS R and LLORENTE JL (2009) The Stem Cell Network model: clinical implications in cancer. Eur Arch Otorhinolaryngol 266:161-70.
5. CASTELLÓN E, CLEMENTI M, HITSCHFELD C, SÁNCHEZ C, BENÍTEZ D, SÁENZ L, CONTRERAS H and HUIDOBRO C. (2006) Effect of leuprolide and cetrorelix on cell growth, apoptosis and GnRH receptor expression in primary cell cultures from human prostate carcinoma. Cancer Invest 24:261-68.
6. CASTELLÓN E, VENEGAS K, SÁENZ L, CONTRERAS H and HUIDOBRO C (2005) Secretion of prostatic specific antigen, proliferative activity and androgen response in epithetial-stromal co-cultures from human prostatic carcinoma. Int J Androl 28:39-46.
7. CELIÀ-TERRASSA T, MECA-CORTÉS O, MATEO F, DE PAZ AM, RUBIO N, ARNAL-ESTAPÉ A, ELL BJ, BERMUDO R, DÍAZ A, GUERRA-REBOLLO M, LOZANO JJ, ESTARÁS C, ULLOA C, ÁLVAREZ-SIMÓN D, MILÀ J, VILELLA R, PACIUCCI R, MARTÍNEZ-BALBÁS M, DE HERREROS AG, GOMIS RR, KANG Y, BLANCO J, FERNÁNDEZ PL and THOMSON TM (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122:1849-68.
8. CHIANG AC, and MASSAGUÉ J (2008) Molecular Basis of Metastasis. N Engl J Med 359:2814-23.
9. CLARKE MF, DICK JE, DIRKS PB, EAVES CJ, JAMIESON CH, JONES DL VISVADER J, WEISSMAN IL and WAHL GM (2006) Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339-44.
10. CLEMENTI M, SÁNCHEZ C, BENÍTEZ D, CONTRERAS HR, HUIDOBRO C, CABEZAS J, ACEVEDO C and CASTELLÓN EA (2009) Gonadotropin releasing hormone analogues induce apoptosis byextrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas. Prostate 69:1025-33.
11. COLLINS AT and MAITLAND NJ (2006) Prostate cancer stem cells. European J Cancer 42:1213-18.
12. COLLINS AT, BERRY PA, HYDE C, STOWER MJ and MAITLAND NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-51.
13. CROKER AK and ALLAN AL (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12:374-90.
14. DEIS (Departamento de Estadísticas e Información de Salud). Defunciones, Mortalidad observada y ajustada por tumores malignos según localización, por Región y sexo. Chile 2000-2009, MINSAL, Chile.
15. DREWA T and STYCZYNSKI J (2008) Can conception of prostate cancer stem cells influence treatment dedicated to patients with disseminated disease? Medical Hypotheses 71:694-99.
16. DUHAGON MA, HURT EM, SOTELO-SILVEIRA JR, ZHANG X and FARRAR WL (2010) Genomic profiling of tumor initiating prostatospheres. BMC Genomics. 11:324.
17. DUNN MW and KAZER MW (2011) Prostate cancer overview. Semin Oncol Nurs 27:241-50.
18. FAN X, LIU S, SU F, PAN Q and LIN T (2012) Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol 30:314-8.
19. FILIP S, MOKRY J, HORACEK J and ENGLISH D (2008) Stem Cells and the Phenomena of Plasticity and Diversity: A Limiting Property of Carcinogenesis. Stem cells and development 17:1031-38.
20. GAO JX (2008) Cancer stem cells: the lessons from pre-cancerous stem cells. J Cell Mol Med 12:67-96.
21. GIL J, STEMBALSKA A, PESZ KA and SASIADEK MM (2008) Cancer stem cells: the theory and perspectives in cancer therapy. J App Genet 49:193-99.
22. GLINSKY GV (2008) "Stemness" Genomics Law Governs Clinical Behavior of Human Cancer: Implications for Decision Making in Disease Management. J Clin Oncol 26:2846-53.
23. HOLLIER BG, EVANS K and MANI SA (2009) The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies. J Mammary Gland Biol Neoplasia 14:29-43.
24. ISHII H, IWATSUKI M, IETA K, OHTA D, HARAGUCHI N, MIMORI K and MORI M (2008) Cancer stem cells and chemoradiation resistance. Cancer Sci 99:1871-77.
25. KAPLAN RN, PSAILA B and LYDEN D (2006) Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. Cancer Metastasis Rev 25:521-9.
26. KELLY K and YIN J (2008) Prostate cancer and metastasis initiating stem cells. Cell Research 18:528-37.
27. KOTB AF, and ELABBADY AA (2011) Prognostic factors for the development of biochemical recurrence after radical prostatectomy. Prostate Cancer 2011:485189.
28. LA PORTA CA (2012) Thoughts about cancer stem cells in solid tumors. World J Stem Cells 4:17-20.
29. LANG SH, FRAME FM and COLLINS AT (2009) Prostate cancer stem cells. J Pathol 217:299-306.
30. LAPIDOT T, SIRARD C, VORMOOR J, MURDOCH B, HOANG T, CÁCERES-CORTÉS J, MINDEN M, PATERSON B, CALIGIURI MA and DICK JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-48.
31. LE TOURNEAU C, FAIVRE S and RAYMOND E (2008) New developments in multitargeted therapy for patients with solid tumours. Cancer Treat Rev 34:37-48.
32. LEWIS MT (2008) Faith, heresy and the cancer stem cell hypothesis. Future Oncol 4:585-89.
33. LI F, TIEDE B, MASSAGUÉ J and KANG Y (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research 17:3-14.
34. LI H, CHEN X, CALHOUN-DAVIS T, CLAYPOOL K and TANG DG (2008) PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 68:1820-5.
35. LOBO NA, SHIMONO Y, QIAN D and CLARKE MF (2007) The Biology of Cancer Stem Cells. Annu Rev Cell Dev Biol 23:675-99.
36. MENDOZA P, SÁNCHEZ C, CONTRERAS HR, VERGARA J, ACEVEDO C, CABEZAS J, HUIDOBRO C, NOÉ G and CASTELLÓN EA. (2009) Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma. Int J Androl 32:607-15.
37. MIKI J and RHIM JS (2008) Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer and Prostatic Diseases 11:32-9.
38. MIKI J, FURUSATO B, LI H, GU Y, TAKAHASHI H, EGAWA S, SESTERHENN IA, MCLEOD DG, SRIVASTAVA S and RHIM JS (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67:3153-61.
39. PARDAL R, CLARKE MF, MORRISON SJ (2003) Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3:895-902.
40. PASCAL LE, OUDES AJ, PETERSEN TW, GOO YA, WALASHEK LS, TRUE LD and LIU AY (2007) Molecular and cellular characterization of ABCG2 in the prostate. BMC Urol 7:6.
41. PATRAWALA L, CALHOUN-DAVIS T, SCHNEIDER-BROUSSARD R and TANG DG (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67:6796-805.
42. PATRAWALA L, CALHOUN T, SCHNEIDER-BROUSSARD R, ZHOU J, CLAYPOOL K and TANG DG (2005) Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65:6207-19.
43. PFEIFFER MJ and SCHALKEN JA (2010) Stem cell characteristics in prostate cancer cell lines. Eur Urol 57:246-54.
44. REYA T, MORRISON SJ, CLARKE MF and WEISSMAN IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-11.
45. ROSS JS, SHEEHAN CE, FISHER HA, KAUFMAN RP JR, KAUR P, GRAY K, WEBB I, GRAY GS, MOSHER R and KALLAKURY BV (2003) Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 9:6357-62.
46. RUIFROK AC and JOHNSTON DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291-9.
47. SÁNCHEZ C, MERCADO A, CONTRERAS HR, MENDOZA P, CABEZAS J, ACEVEDO C, HUIDOBRO C, CASTELLÓN EA (2011) Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins. Prostate 71:1810-7.
48. SÁNCHEZ C, CLEMENTI M, BENÍTEZ D, CONTRERAS H, HUIDOBRO C and CASTELLÓN E (2005) Effect of GnRH analogues on expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma. Prostate 65: 195-202.
49. SÁNCHEZ C, MENDOZA P, CONTRERAS H, VERGARA J, MCCUBREY J, HUIDOBRO C and CASTELLÓN EA (2009) Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs. Prostate 69:1448-59.
50. SETOGUCHI T, TAGA T and KONDO T (2004) Cancer stem cells persist in many cancer cell lines. Cell Cycle 3:414-15.
51. SHAROM FJ (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9:105-27.
52. SHIPITSIN M and POLYAK K (2008) The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Laboratory Investigation 88:459-63.
53. STAVROVSKAYA AA and STROMSKAYA TP (2008) Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry (Mosc) 73:592-604.
54. TAKAO T and TSUJIMURA A (2008) Prostate stem cells: The niche and cell markers. International Journal of Urology 15:289-94.
55. TANG DG, PATRAWALA L, CALHOUN T, BHATIA B, CHOY G, SCHNEIDERB-ROUSSARD R, and JETER C (2007) Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46:1-14.
56. VISVADER JE and LINDEMAN GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Rev 8:755-68.
57. WARD RJ and DIRKS PB (2007) Cancer Stem Cells: At the Headwaters of Tumor Development. Annu Rev Pathol Mech Dis 2:175-89.
58. WELS J, KAPLAN RN, RAFII S and LYDEN D (2008) Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev 22:559-74.
59. WICHA MS, LIU S and DONTU G (2006) Cancer Stem Cells: An Old Idea-A Paradigm Shift. Cancer Res 66:1883-90.
60. WITZ IP (2008) Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100:203-29.
61. YU C, YAO Z, JIANG Y and KELLER ET (2012) Prostate cancer stem cell biology. Minerva Urol Nefrol 64:19-33.
62. ZHOU S, SCHUETZ JD, BUNTING KD, COLAPIETRO AM, SAMPATH J, MORRIS JJ LAGUTINA I, GROSVELD GC, OSAWA M, NAKAUCHI H and SORRENTINO BP (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7: 1028-34.